| Dr Samuel Edwin Schrack, DO | |
|
217 King Street, Laporte, PA 18626-0095 | |
| (570) 946-5101 | |
| (570) 946-4341 |
| Full Name | Dr Samuel Edwin Schrack |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 217 King Street, Laporte, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114926920 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS007012E (Pennsylvania) | Primary |
| Entity Name | Rural Health Corporation Of Northeastern Pennsylvania |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265801112 PECOS PAC ID: 1052362662 Enrollment ID: O20050201000488 |
News Archive
HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.
Be careful of that raunchy joke that gets all the laughs. As funny as folks at work may find it, it's probably hurting morale.
US study results reveal "substantial" quarterly and regional variation in outpatient antibiotic use among older adults, indicating the possible need for targeted programs to reduce unnecessary prescriptions.
Chronic occupational exposure to organic solvents, found in materials such as paints, printing and dry cleaning agents, is widespread all over the world, and is thought to damage the central nervous system.
As World AIDS Day 2008 approaches, a coalition of hundreds of HIV/AIDS medical care providers and advocates, representing dozens of organizations, today sent a letter to Dr. Margaret Chan, Director General of the World Health Organization (WHO), urging an end to harmful single-dose HIV/AIDS treatment as a recommended treatment for expectant mothers and infants worldwide.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Samuel Edwin Schrack, DO 412 Allen St, Montoursville, PA 17754-1510 Ph: (570) 519-1322 | Dr Samuel Edwin Schrack, DO 217 King Street, Laporte, PA 18626-0095 Ph: (570) 946-5101 |
News Archive
HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.
Be careful of that raunchy joke that gets all the laughs. As funny as folks at work may find it, it's probably hurting morale.
US study results reveal "substantial" quarterly and regional variation in outpatient antibiotic use among older adults, indicating the possible need for targeted programs to reduce unnecessary prescriptions.
Chronic occupational exposure to organic solvents, found in materials such as paints, printing and dry cleaning agents, is widespread all over the world, and is thought to damage the central nervous system.
As World AIDS Day 2008 approaches, a coalition of hundreds of HIV/AIDS medical care providers and advocates, representing dozens of organizations, today sent a letter to Dr. Margaret Chan, Director General of the World Health Organization (WHO), urging an end to harmful single-dose HIV/AIDS treatment as a recommended treatment for expectant mothers and infants worldwide.
› Verified 7 days ago
Dr. Eric Warren Longenbach, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 217 King St, Laporte, PA 18626 Phone: 570-946-5101 Fax: 570-946-4341 |